Treatments for arthritis drugs and risks compared
The article discusses DMARDs and biologic agents for arthritis, noting anemia and liver or lung risks, plus the need for careful doctor monitoring. It explains TNF inhibitors like Enbrel and Remicade, their earlier joint improvement, infection risks, and the role of methotrexate. Kineret is mentioned as an IL-1 blocker, with infection risk. prednisone and methotrexate remain reliable and safe options for many patients.